Frontiers in nutrition · 2026
A prediction tool for malnutrition and sarcopenia in patients with gastroenteropancreatic neuroendocrine neoplasms: results from NUTRIGETNE (GETNE-S2109) study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Argente-Pla Maria, Sampedro-Nuñez Miguel Antonio, Garcia-Carbonero Rocio, Custodio Ana, Hernando Jorge, Suarez Lorena, Hernandez-Rienda Lorena, Peiró Inmaculada, Alonso Vicente, Serrano Raquel, Valdés Nuria, Melian Marcos, Febrero Beatriz, Biarnes Josefina, Díaz-Pérez José Ángel, Molina-Cerrillo Javier, Lopez Carlos, Martínez Olmos Miguel Ángel, Merino-Torres Juan Francisco, Capdevila Jaume, Del Olmo-García Maribel, NUTRIGETNE GROUP
Аннотация
INTRODUCTION: Malnutrition and sarcopenia are prevalent among patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), necessitating simple assessment tools to identify potentially malnourished patients. After describing the nutritional status of those receiving anticancer treatment in Spain, the development of a nutrition screening tool for GEP-NENs was proposed as an exploratory objective of the NUTRIGETNE study.
METHODS: Malnutrition was defined by Global Leadership Initiative on Malnutrition (GLIM) criteria. Sarcopenia by European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria. Patients were randomized 4:1 into training and validation sets to build a least absolute shrinkage and selection operator (LASSO) model. The model was corrected by sex, age, and body mass index. Predictors selected according to the area under the curve criterion were then used to fit the optimal model.
RESULTS: This study included 399 patients. Most had grade 1 or 2 (86.2%) tumors, originating mostly in the small intestine (43.9%) and pancreas (41.6%). Prevalence of malnutrition and sarcopenia was 61.9 and 15%, respectively. The predictive model had an external accuracy of 65.3 and 71.2% for malnutrition and sarcopenia, respectively. The stronger predictive factors for malnutrition were poor tumor differentiation (odds ratio [OR]: 4.4; 95% confidence interval [CI]: 1.2-22), nausea/vomiting (OR: 3.4; 95% CI: 1.4-9.3), having difficulties for a long walk (OR: 3; 95% CI: 1.8-5) and diabetes (OR: 2.2; 95% CI: 1.3-3.9). Sarcopenia was correlated with having troubles in activities of daily living (OR: 19.7; 95% CI: 3.1-390.9), or difficulties for a long walk (OR: 6.1; 95% CI: 2.6-15.5).
CONCLUSION: A nomogram based on these models was developed. We generated a diagnostic tool for malnutrition and sarcopenia in patients with GEP-NENs to identify high-risk cases.
METHODS: Malnutrition was defined by Global Leadership Initiative on Malnutrition (GLIM) criteria. Sarcopenia by European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria. Patients were randomized 4:1 into training and validation sets to build a least absolute shrinkage and selection operator (LASSO) model. The model was corrected by sex, age, and body mass index. Predictors selected according to the area under the curve criterion were then used to fit the optimal model.
RESULTS: This study included 399 patients. Most had grade 1 or 2 (86.2%) tumors, originating mostly in the small intestine (43.9%) and pancreas (41.6%). Prevalence of malnutrition and sarcopenia was 61.9 and 15%, respectively. The predictive model had an external accuracy of 65.3 and 71.2% for malnutrition and sarcopenia, respectively. The stronger predictive factors for malnutrition were poor tumor differentiation (odds ratio [OR]: 4.4; 95% confidence interval [CI]: 1.2-22), nausea/vomiting (OR: 3.4; 95% CI: 1.4-9.3), having difficulties for a long walk (OR: 3; 95% CI: 1.8-5) and diabetes (OR: 2.2; 95% CI: 1.3-3.9). Sarcopenia was correlated with having troubles in activities of daily living (OR: 19.7; 95% CI: 3.1-390.9), or difficulties for a long walk (OR: 6.1; 95% CI: 2.6-15.5).
CONCLUSION: A nomogram based on these models was developed. We generated a diagnostic tool for malnutrition and sarcopenia in patients with GEP-NENs to identify high-risk cases.